Stockreport

Two thirds of COVID-19 patients improve after Gilead drug-NEJM [Yahoo! Finance News]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF By Deena BeasleyApril 10 ) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug bei [Read more]